Sobejana, M.; Al Beiramani, M.; Zwezerijnen, G.J.C.; van der Kooi, A.; Raaphorst, J.; Meskers, C.G.M.; van der Esch, M.; van der Laken, C.J.; Steinz, M.M.
Methodology Development for Investigating Pathophysiological [18F]-FDG Muscle Uptake in Patients with Rheumatic Musculoskeletal Diseases. Biomedicines 2025, 13, 465.
https://doi.org/10.3390/biomedicines13020465
AMA Style
Sobejana M, Al Beiramani M, Zwezerijnen GJC, van der Kooi A, Raaphorst J, Meskers CGM, van der Esch M, van der Laken CJ, Steinz MM.
Methodology Development for Investigating Pathophysiological [18F]-FDG Muscle Uptake in Patients with Rheumatic Musculoskeletal Diseases. Biomedicines. 2025; 13(2):465.
https://doi.org/10.3390/biomedicines13020465
Chicago/Turabian Style
Sobejana, Maia, Mustafa Al Beiramani, Gerben J. C. Zwezerijnen, Anneke van der Kooi, Joost Raaphorst, Carel G. M. Meskers, Martin van der Esch, Conny J. van der Laken, and Maarten M. Steinz.
2025. "Methodology Development for Investigating Pathophysiological [18F]-FDG Muscle Uptake in Patients with Rheumatic Musculoskeletal Diseases" Biomedicines 13, no. 2: 465.
https://doi.org/10.3390/biomedicines13020465
APA Style
Sobejana, M., Al Beiramani, M., Zwezerijnen, G. J. C., van der Kooi, A., Raaphorst, J., Meskers, C. G. M., van der Esch, M., van der Laken, C. J., & Steinz, M. M.
(2025). Methodology Development for Investigating Pathophysiological [18F]-FDG Muscle Uptake in Patients with Rheumatic Musculoskeletal Diseases. Biomedicines, 13(2), 465.
https://doi.org/10.3390/biomedicines13020465
